Lung development and function in preterm infants in the surfactant treatment era

A H Jobe1, M Ikegami

  • 1Pulmonary Biology/Neonatology, Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA. JOBEAO@CHMCC.ORG

Insights

Advances in neonatal care have reduced infant mortality for low birth weight infants. However, chronic lung disease remains a challenge, with new research questioning traditional views on lung development and glucocorticoid treatments.

Area of Science:

  • Neonatal Medicine
  • Pulmonary Biology
  • Developmental Pediatrics

Background:

  • Neonatal intensive care advances have decreased mortality in infants under 1-kg birth weight.
  • Despite improved survival, many extremely preterm infants develop chronic lung disease, marked by impaired lung development and alveolarization.
  • Current understanding of antenatal glucocorticoid effects on lung maturation is being re-evaluated based on new experimental data.

Purpose of the Study:

  • To investigate the mechanisms underlying chronic lung disease in very preterm infants.
  • To explore the role of antenatal glucocorticoids and proinflammatory cytokines in lung development and injury.
  • To examine potential differences in lung injury mechanisms between developing and adult lungs.

Main Methods:

  • Review of recent findings from transgenic and experimental models.
  • Analysis of clinical data on surfactant, antenatal glucocorticoid treatments, and ventilation strategies.
  • Investigation of the impact of antenatal proinflammatory exposures and postnatal injury on lung development.

Main Results:

  • Traditional explanations for antenatal glucocorticoid effects on developing lungs are insufficient.
  • Very preterm infants' lungs are vulnerable to ventilation-induced injury due to small gas volumes and delicate tissue.
  • Proinflammatory cytokines may influence both lung development and injury, with potential unique mechanisms in the developing lung.

Conclusions:

  • Chronic lung disease in very preterm infants necessitates a deeper understanding beyond current therapeutic paradigms.
  • Further research into the complex interplay of inflammation, glucocorticoids, and mechanical ventilation is crucial for improving outcomes.
  • Investigating developmental-specific mechanisms of lung injury is essential for targeted therapeutic strategies.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...